(Q51465563)
Statements
1 reference
The HMG-CoA reductase inhibitor cerivastatin lowers advanced glycation end products in patients with type 2 diabetes. (English)
1 reference
März W
1 reference
Scharnagl H
1 reference
Stojakovic T
1 reference
Winkler K
1 reference
Rosinger S
1 reference
Boehm BO
1 reference
1 June 2007
1 reference
115
1 reference
372-375
1 reference
6
1 reference
Identifiers
1 reference